SGO Issues May 1, 2014

sgo-issues

SGO Issues May 1, 2014

SGO editorial appears in ASTRO journal
SGO makes news on FDA’s primary HPV screening approval
Gynecologic Oncology Special Issue: Obesity and Gynecological Cancer
Minimally Invasive and Robotic Gynecologic Surgery Seminar Dec. 11-12
‘Decoding Annie Parker’ premieres May 2

SGO editorial appears in ASTRO journal

The May/June 2014 edition of Practical Radiation Oncology, the official journal of the American Society of Radiation Oncology (ASTRO), features the editorial, “Postoperative radiation therapy for endometrial cancer: Where do we go from here?” by SGO Clinical Practice Committee members Mitchell I. Edelson, MD, Lee-May Chen, MD, and William M. Burke, MD.

The editorial is the result of several months of collaboration between the two medical societies.

In June 2013, ASTRO invited SGO’s Clinical Practice Committee to comment on ASTRO’s proposed evidence-based guideline: The Role of Post-Operative Radiation Therapy for Endometrial Cancer. This clinical practice guideline evaluated the available literature to define standards, address variation in practice patterns, and provide a clinical framework for the use of radiotherapy after surgery.

SGO provided in-depth feedback in response to these guidelines, and ASTRO included some of SGO’s feedback into their guidelines. The SGO Clinical Practice Committee (CPC) wrote the editorial, supporting ASTRO but also to accurately reflect the surgical approach that gynecologic oncologists bring to the treatment of endometrial cancer.

“SGO and ASTRO independently developed working groups to formulate evidence-based guidelines for the treatment of women with endometrial cancer,” explained Dr. Edelson, CPC chair. “The two group’s recommendations are nicely aligned such that SGO and ASTRO felt it was important to collaborate as both groups are committed to seeing that women with endometrial cancer receive the best evidence-based treatment available.”

Dr. Edelson added that the SGO’s Clinical Practice Committee’s recommendations for the appropriate surgical and adjuvant treatment of the patient with endometrial cancer are undergoing peer review.

“The SGO felt it was important in the editorial to bring forth our perspective on the therapeutic options available at the same time as ASTRO’s publication of their guidelines,” he said. “This will allow ASTRO members to better communicate with our members in their local communities to provide highly coordinated care of women with endometrial cancer.”

SGO makes news on FDA’s primary HPV screening approval

SGO’s perspective on the FDA approval of primary HPV screening was covered in numerous media outlets, including the New York Times, Washington Post, Medscape, The Scientist, and RTT News. In addition, SGO Communications Committee Chair Stephanie V. Blank, MD, appeared on CNBC.

Gynecologic Oncology Special Issue: Obesity and Gynecological Cancer

The April issue of Gynecologic Oncology includes a special section edited by Susan C. Modesitt, MD, from the University of Virginia School of Medicine, and Joan Walker, MD, from The University of Oklahoma Health Sciences Center on gynecologic cancer prevention, treatment and survivorship in obese women.

The section brings together researchers studying the influence of obesity on all components of gynecologic cancer care. Papers address public health policy, cancer prevention, all-cause mortality, treatment strategies, translational research, and survivorship. Access the special issue online now.

Minimally Invasive and Robotic Gynecologic Surgery Seminar Dec. 11-12

SGO is partnering with the 6th Annual Seminar on Minimally Invasive & Robotic Gynecologic Surgery led by general chair, Farr Nezhat, MD, FACOG, FACS, and scientific program co-chairs Camran Nezhat, MD, FACOG, FACS, and Ceana Nezhat, MD, FACOG, FACS. This two-day seminar and hands-on workshop will be held Dec. 11-12, 2014, at the Roosevelt Hotel in New York.

‘Decoding Annie Parker’ premieres May 2

Mary Claire-King, PhD, recipient of SGO’s 2014 Innovation Award for identifying BRCA1 and BRCA2 mutations that cause hereditary breast and ovarian cancers, is portrayed by Helen Hunt in the movie “Decoding Annie Parker,” which opens in theatres and will be available On Demand May 2.